ABUNDÂNCIA NATURAL DE 15N E FORMAS DE NITROGÊNIO EM ARGISSOLO CULTIVADO COM EUCALIPTO E ACÁCIA

O nitrogênio e um dos nutrientes mais demandados pelas espécies vegetais, sua presença no solo, sob formas orgânicas ou minerais disponíveis para as plantas, está vinculada à qualidade e quantidade dos resíduos vegetais aportados ao solo. O estudo teve o objetivo de avaliar a influência do cultivo do eucalipto e da acácia na composição das formas orgânicas e inorgânicas de N e, na abundância natural de 15N em um Argissolo Amarelo. Para isso, foram coletadas amostras de solo e serapilheira em monocultivos do Eucalyptus urograndis (clone do Eucalyptus urophylla S. T. Blake x Eucalyptus grandis W. Hill ex Spreng) de ciclo curto (sete anos), sistemas de cultivo de rotação com acácia ( Acacia mangium Willd.) após monocultivo de eucalipto, monocultivo de eucalipto de ciclo longo (24 anos) e mata nativa (Mata Atlântica) como condição original de solo do litoral Norte do Espírito do Santo. Foram avaliados os teores de C orgânico total, N total, N-NH4+, N-NO3-, relação C/N, fracionamento do N orgânico e abundância natural de 15N no solo e serapilheira. Das formas de N-orgânico hidrolisado, o N-amino foi a fração que apresentou maior contribuição (39%), seguida pela fração de N-não identificado (27%), da fração N-amida (18%) e N-hexosamina (15%). O povoamento de acácia promoveu menor abundância natural de 15N e maiores teores de N total e C orgânico no solo e aumentou as formas orgânicas de N-hidrolisado, quando comparado àqueles de eucalipto de ciclo curto. Isso indica o aumento de formas lábeis de N orgânico no solo para as plantas e redução da humificação da matéria orgânica do solo (MOS) de acácia. Nesse sentido, a rotação de cultivos florestais com acácia após eucalipto de ciclo curto contribuiu para o aumento de formas orgânicas no solo, importantes para a nutrição de plantas, por serem potenciais fontes de nutrientes às plantas em curto período de tempo.

Therapeutic efficacy of alternative primaquine regimens to standard treatment in preventing relapses by Plasmodium vivax : A systematic review and meta-analysis

Objective: To compare efficacy and safety of primaquine regimens currently used to prevent relapses by Plasmodium vivax. Methods: A systematic review was carried out to identify clinical trials evaluating efficacy and safety to prevent malaria recurrences by P. vivax of primaquine regimen 0.5 mg/kg/day for 7 or 14 days compared to standard regimen of 0.25 mg/kg/day for 14 days. Efficacy of primaquine according to cumulative incidence of recurrences after 28 days was determined. The overall relative risk with fixed-effects meta-analysis was estimated. Results: For the regimen 0.5 mg/kg/day/7 days were identified 7 studies, which showed an incidence of recurrence between 0% and 20% with follow-up 60-210 days; only 4 studies comparing with the standard regimen 0.25 mg/kg/day/14 days and no difference in recurrences between both regimens (RR= 0.977, 95% CI= 0.670 to 1.423) were found. 3 clinical trials using regimen 0.5 mg/kg/day/14 days with an incidence of recurrences between 1.8% and 18.0% during 330-365 days were identified; only one study comparing with the standard regimen (RR= 0.846, 95% CI= 0.484 to 1.477). High risk of bias and differences in handling of included studies were found. Conclusion: Available evidence is insufficient to determine whether currently PQ regimens used as alternative rather than standard treatment have better efficacy and safety in preventing relapse of P. vivax. Clinical trials are required to guide changes in treatment regimen of malaria vivax.

Therapeutic efficacy of alternative primaquine regimens to standard treatment in preventing relapses by Plasmodium vivax: A systematic review and meta-analysis

Objective: To compare efficacy and safety of primaquine regimens currently used to prevent relapses by Plasmodium vivax. Methods: A systematic review was carried out to identify clinical trials evaluating efficacy and safety to prevent malaria recurrences by P. vivax of primaquine regimen 0.5 mg/kg/day for 7 or 14 days compared to standard regimen of 0.25 mg/kg/day for 14 days. Efficacy of primaquine according to cumulative incidence of recurrences after 28 days was determined. The overall relative risk with fixed-effects meta-analysis was estimated. Results: For the regimen 0.5 mg/kg/day/7 days were identified 7 studies, which showed an incidence of recurrence between 0% and 20% with follow-up 60-210 days; only 4 studies comparing with the standard regimen 0.25 mg/kg/day/14 days and no difference in recurrences between both regimens (RR= 0.977, 95% CI= 0.670 to 1.423) were found. 3 clinical trials using regimen 0.5 mg/kg/day/14 days with an incidence of recurrences between 1.8% and 18.0% during 330-365 days were identified; only one study comparing with the standard regimen (RR= 0.846, 95% CI= 0.484 to 1.477). High risk of bias and differences in handling of included studies were found. Conclusion: Available evidence is insufficient to determine whether currently PQ regimens used as alternative rather than standard treatment have better efficacy and safety in preventing relapse of P. vivax. Clinical trials are required to guide changes in treatment regimen of malaria vivax.